Replies to post #348722 on Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

Ongoing testing could prove B as a broad spectrum anti-viral with uses surpassing covid-19 strain alone. From Feb18 2020- >Interactions center on assessing Brilacidin as a potential novel antiviral therapy for treating Coronaviruses, including COVID-19 and potentially Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV)".